RITA Medical Systems Announces Fourth Quarter and Full Year 2005 Earnings Release Date and Conference Call
February 07 2006 - 6:30AM
PR Newswire (US)
FREMONT, Calif., Feb. 7 /PRNewswire-FirstCall/ -- RITA Medical
Systems, Inc. (NASDAQ:RITA) today announced that it will release
financial results for the fourth quarter and full year ended
December 31, 2005, after the market close on Thursday, February 23,
2006. The Company will also host a conference call and webcast on
Thursday, February 23, 2006 at 2:00 p.m. Pacific Time to discuss
the Company's fourth quarter and full year results, outlook for
2006, and current corporate developments. The dial-in number for
the conference call is 800-219-6110 for domestic participants and
303-262-2211 for international participants. A live webcast of the
conference call will also be available at
http://www.ritamedical.com/. A taped replay of the conference call
will be available beginning approximately one hour after the call's
conclusion and will remain available for 7 days. It can be accessed
by dialing 800-405-2236 for domestic callers and 303-590-3000 for
international callers, both using the passcode 11053235#. Persons
interested in viewing the slides that accompany the conference call
and webcast may access the slideshow via a link provided at the
Company's website at http://www.ritamedical.com/. Any financial and
other statistical information discussed during the call can be
accessed from the home page of RITA's website at
http://www.ritamedical.com/. In addition, an online replay of the
webcast will be available for one year immediately following the
broadcast by accessing the same link. Webcast participants are
encouraged to go to the site at least 15 minutes prior to the start
of the call to register, download and install any necessary audio
software. About RITA Medical Systems, Inc. RITA Medical Systems
develops, manufactures and markets innovative products for cancer
patients including radiofrequency ablation (RFA) systems for
treating cancerous tumors as well as percutaneous vascular and
spinal access systems. The Company's oncology product lines include
implantable ports, some of which feature its proprietary Vortex(R)
technology; tunneled central venous catheters; and safety infusion
sets and peripherally inserted central catheters used primarily in
cancer treatment protocols. The product line also includes the
HABIB 4X resection device which coagulates a "surgical resection
plane" and is designed to facilitate a fast dissection in order to
minimize blood loss and blood transfusion during surgery. The
proprietary RITA RFA system uses radiofrequency energy to heat
tissue to a high enough temperature to ablate it or cause cell
death. In March 2000, RITA became the first RFA Company to receive
specific FDA clearance for unresectable liver lesions in addition
to its previous general FDA clearance for the ablation of soft
tissue. In October 2002, RITA again became the first company to
receive specific FDA clearance, this time for the palliation of
pain associated with metastatic lesions involving bone. The RITA
Medical Systems website is at http://www.ritamedical.com/. The
Company cautions the reader that the planned appearances of Company
personnel, time and/or manner of the live teleconference, webcast
and replays may change for administrative or other reasons outside
the Company's control. DATASOURCE: RITA Medical Systems, Inc.
CONTACT: investors, Doug Sherk, , Jennifer Beugelmans,
+1-415-896-6820, or media, Steve DiMattia, +1-646-277-8706, or ,
all of EVC Group for RITA Medical Systems, Inc.; or Stephen
Pedroff, VP Marketing Communications of RITA Medical Systems, Inc.,
+1-510-771-0400, or Web site: http://www.ritamedical.com/
Copyright
Rita Medical (NASDAQ:RITA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rita Medical (NASDAQ:RITA)
Historical Stock Chart
From Jul 2023 to Jul 2024